168 related articles for article (PubMed ID: 32705438)
1. Specific Smad2/3 Linker Phosphorylation Indicates Esophageal Non-neoplastic and Neoplastic Stem-Like Cells and Neoplastic Development.
Horitani S; Fukui T; Tanimura Y; Matsumoto Y; Miyamoto S; Tanaka T; Tomiyama T; Ikeura T; Ando Y; Nishio A; Okazaki K
Dig Dis Sci; 2021 Jun; 66(6):1862-1874. PubMed ID: 32705438
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Smad2/3 at the specific linker threonine residue indicates slow-cycling esophageal stem-like cells before re-entry to the cell cycle.
Takahashi Y; Fukui T; Kishimoto M; Suzuki R; Mitsuyama T; Sumimoto K; Okazaki T; Sakao M; Sakaguchi Y; Yoshida K; Uchida K; Nishio A; Matsuzaki K; Okazaki K
Dis Esophagus; 2016; 29(2):107-15. PubMed ID: 25168378
[TBL] [Abstract][Full Text] [Related]
3. Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis.
Miyamoto S; Fukui T; Horitani S; Tanimura Y; Matsumoto Y; Suzuki R; Takahashi YU; Kishimoto M; Tomiyama T; Nishio A; Okazaki K; Naganuma M
Anticancer Res; 2021 Oct; 41(10):4789-4799. PubMed ID: 34593428
[TBL] [Abstract][Full Text] [Related]
4. Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
Suzuki R; Fukui T; Kishimoto M; Miyamoto S; Takahashi Y; Takeo M; Mitsuyama T; Sakaguchi Y; Uchida K; Nishio A; Okazaki K
J Crohns Colitis; 2015 Jul; 9(7):565-74. PubMed ID: 25908723
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of Smad2/3 at specific linker threonine indicates slow-cycling intestinal stem-like cells before reentry to cell cycle.
Kishimoto M; Fukui T; Suzuki R; Takahashi Y; Sumimoto K; Okazaki T; Sakao M; Sakaguchi Y; Yoshida K; Uchida K; Nishio A; Matsuzaki K; Okazaki K
Dig Dis Sci; 2015 Feb; 60(2):362-74. PubMed ID: 25185661
[TBL] [Abstract][Full Text] [Related]
6. The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis.
Fukui T; Kishimoto M; Nakajima A; Yamashina M; Nakayama S; Kusuda T; Sakaguchi Y; Yoshida K; Uchida K; Nishio A; Matsuzaki K; Okazaki K
J Gastroenterol; 2011 Apr; 46(4):456-68. PubMed ID: 21229365
[TBL] [Abstract][Full Text] [Related]
7. Smad2/3 Linker Phosphorylation Is a Possible Marker of Pancreatic Stem/Progenitor Cells in the Regenerative Phase of Acute Pancreatitis.
Sakao M; Sakaguchi Y; Suzuki R; Takahashi Y; Kishimoto M; Fukui T; Uchida K; Nishio A; Matsuzaki K; Okazaki K
Pancreas; 2017; 46(5):605-613. PubMed ID: 28099259
[TBL] [Abstract][Full Text] [Related]
8. Long-term model of colitis-associated colorectal cancer suggests tumor spread mechanism and nature of cancer stem cells.
Tanimura Y; Fukui T; Horitani S; Matsumoto Y; Miyamoto S; Suzuki R; Tanaka T; Tomiyama T; Ikeura T; Ando Y; Nishio A; Okazaki K
Oncol Lett; 2021 Jan; 21(1):7. PubMed ID: 33240413
[TBL] [Abstract][Full Text] [Related]
9. A Short-Term Model of Colitis-Associated Colorectal Cancer That Suggests Initial Tumor Development and the Characteristics of Cancer Stem Cells.
Matsumoto Y; Fukui T; Horitani S; Tanimura Y; Suzuki R; Tomiyama T; Honzawa Y; Tahara T; Okazaki K; Naganuma M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511456
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of GLUT1, p63 and phosphorylated histone H1 in head and neck squamous intraepithelial neoplasia: evidence for aberrations in hypoxia-related, cell cycle- and stem-cell-regulatory pathways.
Burstein DE; Nagi C; Kohtz DS; Lumerman H; Wang BY
Histopathology; 2006 May; 48(6):708-16. PubMed ID: 16681687
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
13. Abnormal cell proliferation in the p75NTR-positive basal cell compartment of the esophageal epithelium during squamous carcinogenesis.
Okumura T; Shimada Y; Sakurai T; Hori R; Nagata T; Sakai Y; Tsukada K
Dis Esophagus; 2015 Oct; 28(7):634-43. PubMed ID: 24888722
[TBL] [Abstract][Full Text] [Related]
14. Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer.
Wu Y; Li Q; Zhou X; Yu J; Mu Y; Munker S; Xu C; Shen Z; Müllenbach R; Liu Y; Li L; Gretz N; Zieker D; Li J; Matsuzaki K; Li Y; Dooley S; Weng H
PLoS One; 2012; 7(4):e35684. PubMed ID: 22539990
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
16. Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus: in-depth evaluation in endoscopic mucosal resections.
Toon C; Allanson B; Leslie C; Acott N; Mirzai B; Raftopoulos S; Kumarasinghe MP
Pathology; 2019 Apr; 51(3):253-260. PubMed ID: 30826014
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
[TBL] [Abstract][Full Text] [Related]
18. Reversible Smad-dependent signaling between tumor suppression and oncogenesis.
Sekimoto G; Matsuzaki K; Yoshida K; Mori S; Murata M; Seki T; Matsui H; Fujisawa J; Okazaki K
Cancer Res; 2007 Jun; 67(11):5090-6. PubMed ID: 17545585
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury.
Kassimatis TI; Giannopoulou I; Koumoundourou D; Theodorakopoulou E; Varakis I; Nakopoulou L
J Cell Mol Med; 2006; 10(4):908-21. PubMed ID: 17125594
[TBL] [Abstract][Full Text] [Related]
20. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
